Active · per the CBE, 16 September 2026

Belgian hadron therapy consortium

BE0890078631

Rechtspersoon Private foundation

Herrmann-Debrouxlaan 40, 1160 Oudergem [email protected]

Active for

19 year, 3 months

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

  • Two loss years in a row NBB

    Negative result in 2023 and 2024.

  • Busy address KBO

    20 other companies have their registered office at the same address; threshold 10.

  • Not on Peppol Peppol

    Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2024

Belgian hadron therapy consortium from Oudergem, company number BE0890078631, closed financial year 2024 with a result of € -606 after tax. For that financial year Belgian hadron therapy consortium recorded a gross margin of € -1,144 and equity of € 63,649. Compared with financial year 2023, the result moved from € -3,323 to € -606. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 28, 2025.

What it is worth Healthy

€ 63,649

▼ 1% vs 2023

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -606

▲ 82 % less loss than in 2023

Profit after tax over the fiscal year.

Cash in the bank

€ 78,917

▼ 1% vs 2023

Cash and bank balances on the last day of the fiscal year.

Debts at end 2024

Bank debt

None

No bank loans on the last day of the fiscal year.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
2021202220232024Change 2023 → 2024
Gross margin € -3,596 € -6,570 € -3,545 € -1,144 ▲ € 2,401
Profit after taxes € -3,633 € -6,650 € -3,323 € -606 ▲ € 2,717
Equity € 74,228 € 67,578 € 64,255 € 63,649 ▼ 1%
Total debts € 15,268 € 15,268 € 15,268 € 15,268
Cash € 89,496 € 82,846 € 79,523 € 78,917 ▼ 1%
Retained profit € 74,228 € 67,578 € 64,255 € 63,649 ▼ 1%
Balance sheet total € 89,496 € 82,846 € 79,523 € 78,917 ▼ 1%

Key figures of Belgian hadron therapy consortium, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.

What happened to Belgian hadron therapy consortium?

What happened at Belgian hadron therapy consortium in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2024: loss of € 606. Source: NBB ↗
  • Start of the company according to the CBE. KBO

In short

From € 3,633 loss in 2021 to € 606 loss in 2024.

Establishments

Establishment units

Physical locations of this company

Registered office

Herrmann-Debrouxlaan 40

1160 Oudergem

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number
0890.078.631
VAT number
BE 0890.078.631
Registered office
Herrmann-Debrouxlaan 40, 1160 Oudergem
Names & denominations
Belgian hadron therapy consortium
Enterprise type
Rechtspersoon
Legal form
Private foundation
Legal situation
Normale toestand
Start date
30 May 2007
Peppol
Not registered

Frequently asked questions

What is the address of Belgian hadron therapy consortium?
The registered office of Belgian hadron therapy consortium is located at Herrmann-Debrouxlaan 40, 1160 Oudergem.
Is Belgian hadron therapy consortium still active?
Yes. According to the CBE (16 September 2026) Belgian hadron therapy consortium is active, legal situation “Normale toestand”, started on 30 May 2007.
Is Belgian hadron therapy consortium registered on Peppol?
No, Belgian hadron therapy consortium is currently not registered on the Peppol network.
What is the enterprise number of Belgian hadron therapy consortium?
The enterprise number of Belgian hadron therapy consortium is BE0890078631.
When was Belgian hadron therapy consortium founded?
Belgian hadron therapy consortium was founded on 30 May 2007.
Is Belgian hadron therapy consortium a reliable company?
Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 30 May 2007; 4 annual accounts filed, latest fiscal year 2024.